Morgan Cheatham
InvestorPartner and Head of Healthcare and Life Sciences at Breyer Capital · Board director at ParcelBio · Board director at Folx
New York, New York, United States
Find your path to Morgan
13,367 people in our graph share verified history with Morgan — schools, employers, funds. One of them is your warm intro.
About
Morgan leads healthcare and life sciences investing at Breyer Capital, spanning software, therapeutics, diagnostics, and AI. He previously spent nearly a decade at Bessemer Venture Partners backing companies like Abridge and Hinge Health, and holds a B.S. and M.D. from Brown University.
Likely email· guessed from name + firm domain, not firm-published
- m•••@breyercapital.comreveal70% confident
Board director at ParcelBioYC W24
Intro paths
Morgan went through Y Combinator (Winter 2024) — any YC alum in your network can reach them through the YC community.
In turn, Morgan can intro founders to ParcelBio's investors below.
ParcelBio's investors · 10
Co-founders at ParcelBio
Board director at Folx
Intro paths
In turn, Morgan can intro founders to Folx's investors below.
Folx's investors · 9
Co-founders at Folx
.png)
Experience
- Breyer CapitalPartner and Head of Healthcare and Life Sciencescurrent2025 — present
- First Close PartnersLimited Partnercurrent2020 — presentNew York, New York, United States
- NEJM GroupNEJM AI Editorial Teamcurrent2023 — presentBoston, Massachusetts, United States
- Silver Beech Capital ManagementLimited Partnercurrent2023 — present
- Decoding BioCo-Founder2022 — 2026
- Bessemer Venture PartnersVice President2017 — 2025New York City Metropolitan Area
- National Human Genome Research Institute (NHGRI)Visiting Student2024Bethesda, MD
- Forbes30U302023
- Goldman SachsInvestment Banking Analyst2016Greater New York City Area
- KyruusData Scientist2015 — 2016Greater Boston Area
Skills & more
+12 more
Team LeadershipQuantitative FinanceInvestingMicrosoft OfficeMedical EducationQuality ImprovementHealth Information SystemsPhysiciansPatient SafetyNeuroscienceHospitalsPublic HealthLanguages Latin
From Morgan's professional profile.
Deals · 1
FolxBoard seat
via Breyer Capital · filed Oct 2022 · $30M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Breyer Capital
Frequently asked questions
- Who is Morgan Cheatham?
- Morgan leads healthcare and life sciences investing at Breyer Capital, spanning software, therapeutics, diagnostics, and AI. He previously spent nearly a decade at Bessemer Venture Partners backing companies like Abridge and Hinge Health, and holds a B.S. and M.D. from Brown University.
- Where does Morgan Cheatham work?
- Morgan Cheatham is Partner and Head of Healthcare and Life Sciences at Breyer Capital and Board director at ParcelBio and Board director at Folx.
- What boards does Morgan Cheatham sit on?
- Morgan Cheatham holds tracked board seats at Folx, ParcelBio.
- Where did Morgan Cheatham go to school?
- Morgan Cheatham studied at Harvard Medical School (Pediatrics, Genetics & Genomics Fellowship); The Warren Alpert Medical School of Brown University (Doctor of Medicine - MD); Brown University (Bachelor of Science (B.Sc.), Computational Decision Sciences).
Same school
Also attended Harvard Medical School245
+ 239 more
Also attended The Warren Alpert Medical School of Brown University6
Also attended Brown University644
+ 638 more
Also attended Thomas Jefferson High School for Science and Technology76
+ 70 more
Shared employers
Also worked at NEJM Group3
Also worked at Decoding Bio4
Also worked at Bessemer Venture Partners163
+ 157 more

.png)


















.png)









.png)















.jpeg)


